Security key
929033207
Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR)
CUSIP: 929033207
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 25,547,116
- Total 13F value
- $332,020,908
- Share change
- +20,842,485
- Put/Call ratio
- 35%
- SEC-reported price per share
- $13.08
- Number of holders
- 54
- Value change
- +$261,622,068
- Number of buys
- 46
- Number of sells
- 12
- Shares outstanding
- 53,761,929
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
54
Top holders
10
VOR full security history
Ownership snapshot
Full 13F holder table
Vor Biopharma Inc. SEC filings
Vor Biopharma Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Reprogrammed Interchange LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 18%
13D/G row: Reprogrammed Interchange LLC
Showing 1-6 of 15 holder rows.
Quick read
Reprogrammed Interchange LLC leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Reprogrammed Interchange LLC's linked filing trail.
Comparable ownership
Top 5
Reprogrammed Interchange LLC
18%
ForGrowth III PA B.V.
10%
Paradigm Biocapital Advisors LP
4.5%
5AM Ventures VI, L.P.
3.5%
GREAT POINT PARTNERS LLC
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Reprogrammed Interchange LLC |
13D/G
3/4/5
10%+ Owner
|
18%
|
$48,045,191
1,204,442 shares
|
$0 | 15 Oct 2025 |
| ForGrowth III PA B.V. |
13D/G
|
10%
|
$81,492,203
10,237,714 shares
|
+$25,772,203 | 18 Dec 2025 |
| Paradigm Biocapital Advisors LP |
13D/G
|
4.5%
|
$23,730,000
1,750,000 shares
|
$0 | 31 Dec 2025 |
| 5AM Ventures VI, L.P. |
13D/G
3/4/5
Andrew J. Schwab · 10%+ Owner
|
3.5%
|
$4,422,863
4,422,863 shares
|
$0 | 08 Jul 2025 |
| GREAT POINT PARTNERS LLC |
13D/G
|
3.3%
|
$18,578,651
1,370,107 shares
|
+$1,839,021 | 31 Dec 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.7%
|
$96,577,705
1,982,301 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
25,547,116
Rows available
54
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
35
Q4 2025 holders
54
Holder diff
19
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|